SE

Steven A. Elms

Chairman at ADMA Biologics

Mr. Elms has been a director of ADMA since 2007. Mr. Elms serves as a Managing Partner at Aisling Capital, which he joined in 2000. Previously, he was a Principal in the Life Sciences Investment Banking Group of Hambrecht & Quist. During his five years at Hambrecht & Quist, Mr. Elms was involved in over 60 financing and merger and acquisition transactions, helping clients raise in excess of $3.3 billion in capital.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


ADMA Biologics

3 followers

ADMA Biologics develops plasma-based biologics for the treatment and prevention of certain infectious diseases.


Industries

Employees

51-200

Links